Biosimilars, Shall We Do the Patent Dance?

By Erika Hanson The Affordable Care Act (ACA) is widely known for mandating health insurance coverage. Many of us don’t know that ACA also provided a way for pharmaceutical drugs known as “biologics” to be more affordable to consumers by having a provision known as the Biologics Price Competition and Innovation Act of 2009 (BPCI […]